Trenton, N.J. â¢ A panel of Food and Drug Administration advisers voted against approving a new opioid painkiller with a unique feature for deterring abuse: It releases a deep-blue dye if someone tries to get high by crushing, chewing or snorting pills.
Panelists voted overwhelmingly against approving Intellipharmaceutics Internationalâs generic version of extended-release Oxycontin, a key drug in the U.S. opioid addiction epidemic. The FDA usually follows its advisersâ advice.
Doctors and scient...
Share this post
← Back to Utah